The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations-Reference-Cited by-同舟云学术

The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations

Published:2012-03-09 Issue:3 Volume:341 Page:681-691
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Johnson David E.,Drummond Elena,Grimwood Sarah,Sawant-Basak Aarti,Miller Emily,Tseng Elaine,McDowell Laura L.,Vanase-Frawley Michelle A.,Fisher Katherine E.,Rubitski David M.,Stutzman-Engwall Kim J.,Nelson Robin T.,Horner Weldon E.,Gorczyca Roxanne R.,Hajos Mihaly,Siok Chester J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference48 articles.

1. Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex

2. Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains

3. Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat

4. The Cholinergic Hypothesis of Geriatric Memory Dysfunction

5. Acetylcholine, Histamine, and Cognition: Two Sides of the Same Coin

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy;Frontiers in Cellular Neuroscience;2024-04-04

2. 5-HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action;Biological Psychiatry: Cognitive Neuroscience and Neuroimaging;2023-11

3. Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling;European Journal of Pharmacology;2023-05

4. 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy;2023-02-04

5. THE PARTICIPATION OF HUMORAL MECHANISMS IN THE REGULATION OF THE CONTRACTILE ACTIVITY OF SMOOTH MUSCLE TISSUE OF THE INTESTINE;Bulletin of Problems Biology and Medicine;2023